A Dose-finding Study of ASP4070

Clinical trial NCT03101267 · COMPLETED

Trial details

NCT number: NCT03101267
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhinitis, Allergic, Seasonal

Start date: 2017-04-13
Primary completion: 2018-01-26
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.